Compound HbS or beta thalassaemia heterozygotes (Q66717): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/201007614 / rank | |||
Normal rank | |||
Revision as of 14:32, 14 August 2026
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.)
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_201007614 |
||
| English | Compound HbS or beta thalassaemia heterozygotes |
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.) |
